EFFICACY OF ALBUTEROL MULTIDOSE DRY POWDER INHALER VERSUS PLACEBO IN SUBJECTS 12 YEARS OF AGE AND OLDER WITH PERSISTENT ASTHMA.

被引:0
|
作者
Raphael, G.
Taveras, H.
Iverson, H.
O'Brien, C.
Miller, D.
机构
关键词
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
P74
引用
收藏
页码:A45 / A46
页数:2
相关论文
共 50 条
  • [21] Randomized, double-blind trial evaluating the efficacy and safety of fluticasone propionate and fluticasone propionate/salmeterol delivered via multidose dry powder inhalers in patients with persistent asthma aged 12 years and older
    Raphael, Gordon
    Yiu, Gloria
    Sakov, Anat
    Liu, Siyu
    Caracta, Cynthia
    JOURNAL OF ASTHMA, 2018, 55 (06) : 640 - 650
  • [22] Correct use and ease of use of a placebo dry powder inhaler in subjects with asthma and chronic obstructive pulmonary disease
    Feldman, Gregory J.
    Galkin, Dmitry, V
    Patel, Pinal
    Collison, Kathryn A.
    Sharma, Raj
    CHRONIC RESPIRATORY DISEASE, 2018, 16
  • [23] Comparable efficacy and tolerability of formoterol (Foradil®) administered via a novel multi-dose dry powder inhaler (Certihaler™) or the Aerolizer® dry powder inhaler in patients with persistent asthma
    Dahl, R
    Creemers, JP
    van Noord, J
    Sips, A
    Della Cioppa, G
    Thomson, M
    Andriano, K
    Kottakis, J
    Fashola, T
    RESPIRATION, 2004, 71 (02) : 126 - 133
  • [24] A randomized, 12-week, double-blind, placebo-controlled study comparing formoterol dry powder inhaler with albuterol metered-dose inhaler
    Bensch, G
    Lapidus, RJ
    Levine, BE
    Lumry, W
    Yegen, Ü
    Kiselev, P
    Della Cioppa, G
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2001, 86 (01) : 19 - 27
  • [25] Patient-Reported Outcomes and Quality of Life Improved with Fluticasone Propionate and Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhalers Versus Placebo in Patients with Persistent Asthma
    Raphael, Gordon
    Yiu, Gloria
    Sakov, Anat
    Liu, Siyu
    Caracta, Cynthia
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (02) : AB10 - AB10
  • [26] Dose-Ranging Study to Evaluate the Efficacy and Safety of Four Doses of Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler (FS MDPI) Compared with Fluticasone Propionate (Fp) Mdpi and FS DPI in Subjects with Persistent Asthma
    Steinfeld, Jonathan
    Yiu, Gloria
    Miller, S. David
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 135 (02) : AB6 - AB6
  • [27] Formoterol delivered via the dry powder Aerolizer® inhaler versus albuterol MDI and placebo in mild-to-moderate asthma:: A randomized, double-blind, double-dummy trial
    Pleskow, W
    LaForce, CF
    Yegen, Ü
    Matos, D
    Della Cioppa, G
    JOURNAL OF ASTHMA, 2003, 40 (05) : 505 - 514
  • [28] A 6-month safety and efficacy study of fluticasone propionate and fluticasone propionate/salmeterol multidose dry powder inhalers in persistent asthma
    Mansfield, Lyndon
    Yiu, Gloria
    Sakov, Anat
    Liu, Siyu
    Caracta, Cynthia
    ALLERGY AND ASTHMA PROCEEDINGS, 2017, 38 (04) : 264 - 276
  • [29] Dose-related efficacy of budesonide administered via a dry powder inhaler in the treatment of children with moderate to severe persistent asthma
    Shapiro, G
    Bronsky, EA
    LaForce, CF
    Mendelson, L
    Pearlman, D
    Schwartz, RH
    Szefler, SJ
    JOURNAL OF PEDIATRICS, 1998, 132 (06): : 976 - 982
  • [30] Efficacy and Safety of a Pressurized Metered-Dose Inhaler in Older Asthmatics: Comparison to a Dry Powder Inhaler in a 12-Week Randomized Trial
    Woo, Seong-Dae
    Ye, Young-Min
    Lee, Youngsoo
    Lee, So-Hee
    Shin, Yoo Seob
    Park, Joo Hun
    Choi, Hyunna
    Lee, Hyun-Young
    Shin, Hyun-Jung
    Park, Hae-Sim
    ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2020, 12 (03) : 454 - 466